Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

Khan, 2012, Epidemiology, clinical presentation, and patterns of drug resistance of Salmonella Typhi in Karachi, Pakistan, J Infect Dev Ctries, 6, 704, 10.3855/jidc.1967

Lin, 2000, The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam, Am J Trop Med Hyg, 62, 644, 10.4269/ajtmh.2000.62.644

10.2471/BLT.06.039818

Levine, 2003, Use of vaccines for the prevention of typhoid fever, Indian Pediatr, 40, 1029

10.1007/s10654-005-7454-6

10.1001/archinte.1995.00430210041007

10.3201/eid1611.100388

10.1371/journal.pone.0029119

10.1016/S0264-410X(99)00231-5

10.1056/NEJM198710293171801

Yang, 2001, Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China, Bull World Health Organ, 79, 625

10.1016/j.vaccine.2012.06.015

10.1056/NEJMoa0807521

10.1128/CVI.00532-10

World Heath Organization. Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines, 2013. Available at: http://www.who.int/biologicals/areas/vaccines/TYPHOID_BS2215_doc_v1.14_WEB_VERSION.pdf . Accessed 21 January2015.

10.1586/erv.11.8

10.1111/j.1365-2567.2004.01971.x

10.1086/648964

10.1128/IAI.72.11.6586-6588.2004

10.1056/NEJM200104263441701

10.1056/NEJM200310023491423

10.1111/j.1365-2249.2004.02439.x

10.1016/j.vaccine.2013.02.006

10.1016/j.vaccine.2014.02.050

Chinnasami, 2013, Safety and immunogenicity of Salmonella Typhi Vi conjugate vaccine (Peda Typh) in children up to five years, Int J Sci Res Publ, 3, 1

10.1016/j.vaccine.2009.11.051

10.1016/S1473-3099(13)70241-X

10.4161/hv.18350

10.3201/eid1102.040422

Owais, 2010, Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan, Pediatr Infect Dis J, 29, 1035, 10.1097/INF.0b013e3181e39f8b

Chattopadhyay, 2012, Guinea pigs in human form: clinical trials in unethical settings, Lancet, 379, e53, 10.1016/S0140-6736(12)60855-1

10.1371/journal.pone.0100651

10.1086/314989

10.1111/j.1365-3083.2011.02535.x

10.1128/CVI.13.4.507-510.2006

10.1111/j.1365-2567.2011.03411.x

10.1038/icb.2014.48